Sherifa Mostafa Abu-Bakr

Sherifa Mostafa Abu-Bakr

Auto-generated profile, based on publicly available information

Sherifa Mostafa Abu-Bakr

National Research Centre

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMona A. Abdullaziz
Mona A. Abdullaziz
HAHeba Abdel-Mohsen
Heba Abdel-Mohsen
AKAhmed M. El Kerdawy
Ahmed M. El Kerdawy
FRFatma A.F. Ragab
Fatma A.F. Ragab
MAMamdouh M. Ali
Mamdouh M. Ali
HDHoda I. El Diwani
Hoda I. El Diwani

7 August 2011 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
FBFatma Bassyouni
Fatma Bassyouni
SASherifa M. Abu-Bakr
Sherifa M. Abu-Bakr
Mohamed Abdel-RehimMohamed Abdel-Rehim
Mohamed Abdel-Rehim

8 June 2018 in Molecules
Verified
Journal Article
Open access
PDF file
RBRita Borik
Rita Borik
NFNagwa M. Fawzy
Nagwa M. Fawzy
SASherifa M. Abu-Bakr
Sherifa M. Abu-Bakr
MAMagdy Sayed Aly
Magdy Sayed Aly
Curcumin, a widely utilized flavor and coloring agent in food, has been shown to demonstrate powerful antioxidant, antitumor promoting and anti-inflammatory properties in vitro and in vivo. In the present work, synthesis of new heterocyclic derivatives based on Curcumin was studied. Compound 3 was synthesized via the reaction of furochromone carbaldehyde (1) with Curcumin (2) using pipredine as catalyst. Also, novel, 4,9-dimethoxy-5H-furo [3, 2-g] chromen-5-one derivatives 4a–d, 6a–d, 7, 8a–d, 9 and 10 were synthesized by the reactions of furochromone carbaldehyde (1) with different reagents (namely: appropriate amine 3a–d, appropriate hydrazine 5a–d, hydroxylamine hydrochloride, urea/thiourea, malononitrile, malononitrile with hydrazine hydrate). The structure of the synthesized products had been confirmed from their spectroscopic data (IR, 1H-NMR, 13C-NMR and mass spectra). In the present investigation, the newly synthesized products were screened using the MTT colorimetric assay for their in vitro inhibition capacity in two human cancer cell lines (hepatocellular carcinoma (HEPG2) and breast cancer (MCF-7) as well as the normal cell line (human normal melanocyte, HFB4) in comparison to the known anticancer drugs: 5-flurouracil and doxorubicin. The anticancer activity results indicated that the synthesized products 4c and 8b showed growth inhibition activity against HEPG2 cell line and synthesized products 4b and 8a showed growth inhibition activity against MCF-7, but with varying intensities in comparison to the known anticancer drugs, 5-flurouracil and doxorubicin. Cyclin dependent kinase 2 (CDK2), a major cell cycle protein, was identified as a potential molecular target of Curcumin. Furthermore, Curcumin induced G1 cell cycle arrest, which is regulated by CDK2 in cancer cells. Therefore, we used molecular modelling to study in silico the possible inhibitory effect of CDK2 by Curcumin derivatives as a possible mechanism of these compounds as anticancer agents. The molecular docking study revealed that compounds 4b, 8a and 8b were the most effective compounds in inhibiting CDk2, and, this result was in agreement with cytotoxicity assay.

9 June 2014 in RSC Advances
Verified
Journal Article
Closed access
PDF file
FBFatma Bassyouni
Fatma Bassyouni
SASherifa M. Abu-Baker
Sherifa M. Abu-Baker
KMKhaled Mahmoud
Khaled Mahmoud
MMMaysa Moharam
Maysa Moharam
SESally S. El-Nakkady
Sally S. El-Nakkady
Mohamed Abdel-RehimMohamed Abdel-Rehim
Mohamed Abdel-Rehim
In the present study, versatile multifunctional unreported triazolo[1,5-a]quinoline derivatives were prepared. Compounds 1–19 were synthesized by adopting appropriate synthetic routes and were pharmacologically evaluated for their in vitro anticancer activity against human cancer cell lines: hepatocellular liver carcinoma (HEPG2) and Caucasian breast adenocarcinoma (MCF-7), in addition to their antibacterial and antifungal activities. Compound 4 demonstrated strong inhibitory effects against breast cancer (MCF-7), whereas compounds 8 and 19 exhibited moderate activity against breast carcinoma cell line MCF-7. Compounds 16 and 19 gave moderate activity against liver carcinoma cell line HEPG2. The antimicrobial activity of the prepared compounds was tested against bacteria and fungi. Among them, the results of antimicrobial activity indicated that compounds 4, 9, 11, 13, 15, 17, 18 and 19 were the most active compounds. Compound 4 exhibited strong activity against Fusarium sp., whereas compounds 9, 11, 15, 17, 18 and 19 showed high activity against Escherichia coli. More specifically, compound 17 displayed a high inhibitory effect against Bacillus cereus, Escherichia coli and Rhizoctonia sp.

1 March 2010 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
EEEslam El-Sawy
Eslam El-Sawy
FBFatma Bassyouni
Fatma Bassyouni
SASherifa Abu-Bakr
Sherifa Abu-Bakr
HRHanaa Rady
Hanaa Rady
MAMohamed Abdlla
Mohamed Abdlla
Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives: Starting from 1-benzyl- (2a) and 1-benzoyl-3-bromoacetyl indoles (2b) new heterocyclic, 2-thioxoimidazolidine (4a, b), imidazolidine-2,4-dione (5a, b), pyrano(2,3-d)imida-zole (8a, band9a, b), 2-substituted quinoxaline (11a, b-17a, b) and triazolo(4,3-a)quinoxaline derivatives (18a, band19a, b) were synthesized and evaluated for their antimicrobial and anticancer activities. Antimicrobial activity screening performed with concentrations of 0.88, 0.44 and 0.22 μg mm-2showed that 3-(1-substituted indol-3-yl)quinoxalin-2(1H)ones (11a, b) and 2-(4-methyl piperazin-1-yl)-3-(1-substituted indol-3-yl) quinoxalines (15a, b) were the most active of all the tested compounds towardsP. aeruginosa, B. cereusandS. aureuscompared to the reference drugs cefotaxime and piperacillin, while 2-chloro-3-(1-substituted indol-3-yl)quinoxalines (12a, b) were the most active against C.albicanscompared to the reference drug nystatin. On the other hand, 2-chloro-3-(1-benzyl indol-3-yl) quinoxaline12adisplay potent efficacy against ovarian cancer xenografts in nude mice with tumor growth suppression of 100.0 ± 0.3 %.

18 February 2012 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
FBFatma Bassyouni
Fatma Bassyouni
SASherifa M. Abu-Bakr
Sherifa M. Abu-Bakr
KHKhaled Hegab
Khaled Hegab
WEWafaa El-Eraky
Wafaa El-Eraky
AEAhmed El-Beih
Ahmed El-Beih
Mohamed Abdel-RehimMohamed Abdel-Rehim
Mohamed Abdel-Rehim